| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Staphylococcus aureus Staphopain B |
|---|
| Description | 220-393aa; Full Length. MW: 47.3kD. Purity >90% as determined by SDS-PAGE. Cysteine protease able to degrade elastin, fibrogen, fibronectin and kininogen. Exhibits a strong preference for substrates where arginine is preceded by a hydrophobic amino acid. Promotes detachment of primary human keratinocytes. Along with other extracellular proteases is involved in colonization and infection of human tissues. |
|---|
| Size | 0.01 mg (E-Coli), 0.01 mg (Yeast), 0.05 mg (E-Coli), 0.05 mg (Yeast), 0.1 mg (E-Coli) |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [Staphylococcal cysteine proteinase B; Staphylopain B] |
|---|
| Gene, Accession, CAS # | sspB, Accession: WP_001088793.1 |
|---|
| Catalog # | MBS1358778 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Staphylococcus aureus Staphopain B from MYBIOSOURCE INC. |
|---|
| Product Specific References | Genetic characterization of staphopain genes in Staphylococcus aureus.Golonka E., Filipek R., Sabat A., Sinczak A., Potempa J.Biol. Chem. 385:1059-1067(2004) Staphostatinsan expanding new group of proteinase inhibitors with a unique specificity for the regulation of staphopains, Staphylococcus spp. cysteine proteinases.Rzychon M., Sabat A., Kosowska K., Potempa J., Dubin A.Mol. Microbiol. 49:1051-1066(2003) The staphostatin-staphopain complexa forward binding inhibitor in complex with its target |
|---|
| 产品资料 |
|
|